Hologic Stock Forecast, Price & News

Hologic (NASDAQ:HOLX) Frequently Asked Questions

Is Hologic a buy right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Hologic stock.
View analyst ratings for Hologic or view top-rated stocks.

How has Hologic's stock price been impacted by Coronavirus (COVID-19)?

Hologic's stock was trading at $43.78 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, HOLX stock has increased by 73.7% and is now trading at $76.05.
View which stocks have been most impacted by COVID-19.

When is Hologic's next earnings date?

Hologic is scheduled to release its next quarterly earnings announcement on Wednesday, January 26th 2022.
View our earnings forecast for Hologic.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) posted its quarterly earnings results on Sunday, October, 31st. The medical equipment provider reported $1.61 EPS for the quarter, beating analysts' consensus estimates of $1.01 by $0.60. The medical equipment provider had revenue of $1.32 billion for the quarter, compared to analysts' expectations of $1.04 billion. Hologic had a net margin of 33.22% and a trailing twelve-month return on equity of 57.61%. Hologic's revenue for the quarter was down 2.3% on a year-over-year basis. During the same period in the previous year, the firm posted $2.07 earnings per share.
View Hologic's earnings history.

What guidance has Hologic issued on next quarter's earnings?

Hologic issued an update on its first quarter 2022 earnings guidance on Monday, November, 8th. The company provided earnings per share (EPS) guidance of $1.150-$1.250 for the period, compared to the Thomson Reuters consensus estimate of $0.960. The company issued revenue guidance of $1.10 billion-$1.15 billion, compared to the consensus revenue estimate of $991.63 million.

What price target have analysts set for HOLX?

10 Wall Street analysts have issued 12-month price targets for Hologic's shares. Their forecasts range from $76.00 to $95.00. On average, they expect Hologic's stock price to reach $86.56 in the next twelve months. This suggests a possible upside of 13.8% from the stock's current price.
View analysts' price targets for Hologic or view top-rated stocks among Wall Street analysts.

Who are Hologic's key executives?

Hologic's management team includes the following people:

• Stephen P. MacMillan, Chairman, President & Chief Executive Officer
• Karleen Marie Oberton, Chief Financial Officer
• Jay A. Stein, Chairman-Emeritus, Chief Technology Officer & SVP
• Patricia K. Dolan, Secretary & Vice President
• Jan Verstreken, Group President-International

What is Steve MacMillan's approval rating as Hologic's CEO?

283 employees have rated Hologic CEO Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among Hologic's employees.

Who are some of Hologic's key competitors?

Some companies that are related to Hologic include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Edwards Lifesciences (EW), Becton, Dickinson and (BDX), Boston Scientific (BSX), DexCom (DXCM), IDEXX Laboratories (IDXX), Baxter International (BAX), ResMed (RMD), STERIS (STE), Insulet (PODD), Masimo (MASI) and Teleflex (TFX).
View all of HOLX's competitors.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.42%), Wellington Management Group LLP (2.59%), Geode Capital Management LLC (2.13%), Parnassus Investments LLC (1.63%), Nordea Investment Management AB (1.04%) and Barrow Hanley Mewhinney & Strauss LLC (0.99%). Company insiders that own Hologic stock include Benjamin Jordan Cohn, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Peter J Valenti III, Sally Crawford, Sean S Daugherty and Stephen P Macmillan.
View institutional ownership trends for Hologic.

Which major investors are selling Hologic stock?

HOLX stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Renaissance Technologies LLC, Arrowstreet Capital Limited Partnership, Invesco Ltd., State of Michigan Retirement System, Sumitomo Mitsui Trust Holdings Inc., Janus Henderson Group PLC, and Balyasny Asset Management LLC. Company insiders that have sold Hologic company stock in the last year include Benjamin Jordan Cohn, Kevin R Thornal, and Sean S Daugherty.
View insider buying and selling activity for Hologic or view top insider-selling stocks.

Which major investors are buying Hologic stock?

HOLX stock was purchased by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Caisse DE Depot ET Placement DU Quebec, Nordea Investment Management AB, Retirement Systems of Alabama, Russell Investments Group Ltd., Jennison Associates LLC, NN Investment Partners Holdings N.V., and AustralianSuper Pty Ltd.
View insider buying and selling activity for Hologic or or view top insider-buying stocks.

How do I buy shares of Hologic?

Shares of HOLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $76.05.

How much money does Hologic make?

Hologic has a market capitalization of $19.12 billion and generates $5.63 billion in revenue each year. The medical equipment provider earns $1.87 billion in net income (profit) each year or $7.20 on an earnings per share basis.

How many employees does Hologic have?

Hologic employs 6,705 workers across the globe.

Does Hologic have any subsidiaries?

The following companies are subsidiares of Hologic: Focal Therapeutics.

When was Hologic founded?

Hologic was founded in 1985.

What is Hologic's official website?

The official website for Hologic is www.hologic.com.

Where are Hologic's headquarters?

Hologic is headquartered at 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752.

How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The medical equipment provider can be reached via phone at (508) 263-2900, via email at [email protected], or via fax at 781-890-8031.